Home » Stocks » FMS

Fresenius Medical Care AG & Co. (FMS)

Stock Price: $42.24 USD -0.23 (-0.54%)
Updated November 23, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 24.74B
Revenue (ttm) 17.48B
Net Income (ttm) 1.20B
Shares Out 585.67M
EPS (ttm) 3.69
PE Ratio 11.45
Forward PE 13.64
Dividend $0.72
Dividend Yield 1.70%

Stock Quote

Trading Day November 23
Last Price $42.24
Previous Close $42.47
Change ($) -0.23
Change (%) -0.54%
Day's Open 42.65
Day's Range 41.94 - 42.67
Day's Volume 115,866
52-Week Range 29.17 - 46.55

More Stats

Market Cap 24.74B
Enterprise Value 37.51B
Earnings Date (est) Feb 23, 2021
Ex-Dividend Date Aug 28, 2020
Shares Outstanding 585.67M
Float n/a
EPS (basic) 1.98
EPS (diluted) 3.69
FCF / Share 2.37
Dividend $0.72
Dividend Yield 1.70%
Earnings Yield 8.74%
FCF Yield 5.88%
Payout Ratio 33.10%
Shares Short 821,165
Short Ratio 3.05
Short % of Float n/a
Beta 1.03
PE Ratio 11.45
Forward PE 13.64
P/FCF Ratio 17.02
PS Ratio 1.42
PB Ratio 1.83
Revenue 17.48B
Operating Income 2.20B
Net Income 1.20B
Free Cash Flow 1.45B
Net Cash -12.77B
Net Cash / Share -21.81
Gross Margin 29.91%
Operating Margin 12.56%
Profit Margin 6.90%
FCF Margin 8.32%
ROA 4.54%
ROE 12.23%
ROIC 11.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (22)

Buy 11
Overweight 3
Hold 8
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$48.28*
(14.30% upside)
Low
39.6
Current: $42.24
High
55.3
Target: 48.28
*Average 12-month price target from 20 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue17,47716,54717,78416,57015,45515,83214,61013,80012,57111,844
Revenue Growth5.62%-6.95%7.33%7.21%-2.38%8.36%5.87%9.78%6.13%-
Gross Profit5,3965,1556,0185,6165,1774,9964,7384,6014,1523,835
Operating Income2,1962,9642,2952,3502,1002,2302,2302,2012,0441,915
Net Income1,2001,9821,2801,1449551,0451,1101,1871,071979
Shares Outstanding307306306305301301303300298296
Earnings Per Share1.983.232.081.871.571.731.831.941.761.62
EPS Growth-38.6%55.05%11.53%19.17%-9.28%-5.48%-5.68%10.26%8.33%-
Dividend Per Share0.660.630.360.440.440.530.490.910.950.82
Dividend Growth3.64%76.54%-18.64%0.46%-17.82%8.78%-46.21%-4.11%16.56%-
Operating Cash Flow2,5672,0622,1921,9321,7671,8612,0352,0391,4461,368
Capital Expenditures-1,113-1,003-841-915-843-920-728-666-571-508
Free Cash Flow1,4541,0591,3511,0179239411,3071,373876861
Cash & Equivalents1,0082,146978709550634683688457523
Total Debt13,7827,5467,4488,1328,6469,4668,4178,2987,2115,880
Net Cash / Debt-12,775-5,401-6,470-7,423-8,097-8,832-7,735-7,610-6,754-5,357
Assets32,93526,24224,02525,50425,36525,38123,12022,32619,53317,095
Liabilities19,70713,34013,19714,45213,84114,52812,98712,59511,0619,291
Book Value11,95811,7589,8209,9789,8879,4439,2358,9437,9027,377
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Fresenius Medical Care AG & Co.
Country Germany
Employees 126,463
CEO Rice Powell

Stock Information

Ticker Symbol FMS
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier NYSE: FMS
IPO Date September 19, 1996

Description

Fresenius Medical Care AG & KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides pharmacy services, vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2019, it operated 3,994 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.